English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 36 Help

Selected(0)Clear Items/Page:    Sort:
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges Review article
2024
Authors:  Li, Chang Yun;  Wang, Wanhe;  Leung, Chung Hang;  Yang, Guan Jun;  Chen, Jiong
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:27.7/31.3 | Submit date：2024/06/05
Breast Cancer  Histone Demethylation  Kdm5  Kdm5 Inhibitors  Therapeutic Target  
CHHM: a Manually Curated Catalogue of Human Histone Modifications Revealing Hotspot Regions and Unique Distribution Patterns Journal article
Wendong Ma, DING XIAOFAN, Jiajia Xu, Terence Chuen Wai Poon. CHHM: a Manually Curated Catalogue of Human Histone Modifications Revealing Hotspot Regions and Unique Distribution Patterns[J]. International Journal of Biological Sciences, 2024, 20(10), 3760-3772.
Authors:  Wendong Ma;  DING XIAOFAN;  Jiajia Xu;  Terence Chuen Wai Poon
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.3 | Submit date：2024/08/22
Curated Catalogue Of Human Histone Modifications (Chhm)  Histone-dna Crosslink  Hotspot Region  Human Histone Modification  Modification Inference  
DNA polymerase delta governs parental histone transfer to DNA replication lagging strand Journal article
Tian, Congcong, Zhang, Qin, Jia, Jing, Zhou, Jiaqi, Zhang, Ziwei, Karri, Srinivasu, Jiang, Jiuhang, Dickinson, Quinn, Yao, Yuan, Tang, Xiaorong, Huang, Yuxin, Guo, Ting, He, Ziwei, Liu, Zheng, Gao, Yuan, Yang, Xinran, Wu, Yuchun, Chan, Kui Ming, Zhang, Daoqin, Han, Junhong, Yu, Chuanhe, Gan, Haiyun. DNA polymerase delta governs parental histone transfer to DNA replication lagging strand[J]. Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(20), e2400610121.
Authors:  Tian, Congcong;  Zhang, Qin;  Jia, Jing;  Zhou, Jiaqi;  Zhang, Ziwei; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:9.4/10.8 | Submit date：2024/06/05
Dna Polymerase δ  Epigenetic Inheritance  Histone Chaperone  Parental Histone Transfer  Pol32  
Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy Journal article
Wu, Ke Jia, Chen, Qi, Leung, Chung Hang, Sun, Ning, Gao, Fei, Chen, Zhaoyang. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy[J]. Drug Discovery Today, 2024, 29(2), 103878.
Authors:  Wu, Ke Jia;  Chen, Qi;  Leung, Chung Hang;  Sun, Ning;  Gao, Fei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.5/7.3 | Submit date：2024/02/22
Chromatin Remodeling  Epigenetics  Heart Failure  Histone Modification  Pathological Cardiac Hypertrophy  
Codelivery of vorinostat and chloroquine by autophagy-inhibitory hollow ZrO2 nanoshells for synergistic combination chemotherapy Journal article
Chen, Jian Li, Jia, Xiao Hui, Xia, Xinyue, Wu, Xuan, Xu, Yan Neng, Yuan, Gang, Gu, Ze Yun, Luo, Kathy Qian, Yuan, Ming Heng, Jiang, Ruibin, Wang, Jianfang, Zhu, Xiao Ming. Codelivery of vorinostat and chloroquine by autophagy-inhibitory hollow ZrO2 nanoshells for synergistic combination chemotherapy[J]. Chemical Engineering Journal, 2023, 471(144740), 1-17.
Authors:  Chen, Jian Li;  Jia, Xiao Hui;  Xia, Xinyue;  Wu, Xuan;  Xu, Yan Neng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:13.3/13.2 | Submit date：2023/08/03
Autophagy  Chloroquine  Histone Deacetylase Inhibitor  Vorinostat  Zirconium Dioxide  
Editorial: Epigenetics of metabolism, immunology and aging Other
2023-01-18
Authors:  Zeng,Hailuan;  Lu,Xiaofan;  Sun,Heng;  Wang,Haitao
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/03
Methylation  Histone Modification  Metabolism  Cancer  Epigenetic Age  Immune  
Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors Journal article
Chen, Geer, Zhu, Xiaoyu, Li, Jiaqi, Zhang, Yao, Wang, Xiaoxuan, Zhang, Ren, Qin, Xinchen, Chen, Xi, Wang, Junyi, Liao, Weilin, Wu, Zongjin, Lu, Lu, Wu, Weiyu, Yu, Haijie, Ma, Lijuan. Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors[J]. Pharmacological Research, 2022, 185.
Authors:  Chen, Geer;  Zhu, Xiaoyu;  Li, Jiaqi;  Zhang, Yao;  Wang, Xiaoxuan; et al.
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:9.1/9.0 | Submit date：2023/01/31
Acetylation  Anacardic ACid (Pubchem Cid: 167551)  C646 (Pubchem Cid: 1285941)  Celastrol  Celastrol (Pubchem Cid: 122724)  Ci994 (Pubchem Cid: 2746)  Hdac  Histone Modification  Lung Cancer  Mc1568 (Pubchem Cid: 71311876)  Ms275 (Pubchem Cid: 4261)  Nu9056 (Pubchem Cid: 72201043)  Saha (Pubchem Cid: 5311)  
Npac Is A Co-factor of Histone H3K36me3 and Regulates Transcriptional Elongation in Mouse Embryonic Stem Cells Journal article
Yu, Sue, Li, Jia, Ji, Guanxu, Ng, Zhen Long, Siew, Jiamin, Lo, Wan Ning, Ye, Ying, Chew, Yuan Yuan, Long, Yun Chau, Zhang, Wensheng, Guccione, Ernesto, Loh, Yuin Han, Jiang, Zhi Hong, Yang, Henry, Wu, Qiang. Npac Is A Co-factor of Histone H3K36me3 and Regulates Transcriptional Elongation in Mouse Embryonic Stem Cells[J]. Genomics, Proteomics and Bioinformatics, 2022, 20(1), 110-128.
Authors:  Yu, Sue;  Li, Jia;  Ji, Guanxu;  Ng, Zhen Long;  Siew, Jiamin; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:11.5/10.3 | Submit date：2023/01/30
Histone H3k36me3  Npac  Pluripotency  Reprogramming  Transcriptional Elongation  
Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia Journal article
Rong, Dade, Chen, Xiaomin, Xiao, Jing, Liu, Daiyuan, Ni, Xiangna, Tong, Xiuzhen, Wang, Haihe. Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia[J]. Heliyon, 2022, 8(9), e10610.
Authors:  Rong, Dade;  Chen, Xiaomin;  Xiao, Jing;  Liu, Daiyuan;  Ni, Xiangna; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.4/3.9 | Submit date：2022/10/06
Acute Myeloid Leukemia  Chemotherapy  Classification  Histone  Methylation  
Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A Journal article
Chao Yang, Dan Li, Shaohong Zang, Lei Zhang, Zhangfeng Zhong, Yingtang Zhou. Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Chao Yang;  Dan Li;  Shaohong Zang;  Lei Zhang;  Zhangfeng Zhong; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:4.4/5.0 | Submit date：2022/08/24
Anticancer Activity  Demethylation  Epigenetics  Histone Modifications  Lsd1  Lysine Methylation  Signaling Pathway  Targets